As the number of incarcerated persons who use drugs increases in many countries, it is important to understand the nature of drug use in prison by exploring how substance use patterns change from before to during incarceration. In this study, we rely on cross-sectional, self-report data from The Norwegian Offender Mental Health and Addiction (NorMA) study to identify the nature of changes in drug use among incarcerated respondents who reported having used either narcotics, non-prescribed medications, or both, during the 6 months before their incarceration (n = 824). Results show that about 60% (n = 490) stop using drugs. Of the remaining 40% (n = 324), about 86% changed their use patterns. Most commonly, incarcerated people stopped using stimulants and started using opioids; switching from cannabis to stimulants was the least common change. Overall, the study illustrates that the prison context leads most individuals to change their use patterns, some in unanticipated ways.
AebiM. F.HashimotoY. Z.TiagoM. M. (2019). Probation and prisons in Europe, 2018: Key findings of the SPACE reports. Council of Europe. www.unil.ch/space
2.
AndersenS. N.HyattJ. M. (2018). Building a policy “Sandbox” an opportunity for comparative sentencing and corrections. Federal Sentencing Reporter, 31(1), 14–20.
3.
AndersenS. N.SkardhamarT. (2017). Pick a number: Mapping recidivism measures and their consequences. Crime & Delinquency, 63(5), 613–635.
4.
BaltieriD. A. (2014). Predictors of drug use in prison among women convicted of violent crimes. Criminal Behaviour and Mental Health, 24(2), 113–128.
5.
BensonB. L.KimI.RasmussenD. W.ZhehlkeT. W. (1992). Is property crime caused by drug use or by drug enforcement policy?Applied Economics, 24(7), 679–692.
6.
Bi-MohammedZ.WrightN. M.HeartyP.KingN.GavinH. (2017). Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses. Drug and Alcohol Dependence, 171, 122–131
7.
BinswangerI. A.NowelsC.CorsiK. F.GlanzJ.LongJ.BoothR. E.SteinerJ. F. (2012). Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors. Addiction Science & Clinical Practice, 7(1), 1–9.
8.
BoysA.FarrellM.BebbingtonP.BrughaT.CoidJ.JenkinsR.LewisG.MarsdenJ.MeltzerH.SingletonN.TaylorC. (2002). Drug use and initiation in prison: Results from a national prison survey in England and Wales. Addiction, 97(12), 1551–1560.
9.
BuktenA.LundI. O.KinnerS. A.RognliE. B.HavnesI. A.MullerA. E.StavsethM. R. (2020). Factors associated with drug use in prison–results from the Norwegian offender mental health and addiction (NorMA) study. Health & Justice, 8, 1–10.
10.
BuktenA.LundI. O.RognliE. B.StavsethM. R.LobmaierP.SkurtveitS.ClausenT.KunøeN. (2015). The Norwegian offender mental health and addiction study–design and implementation of a national survey and prospective cohort study. Substance Abuse: Research and Treatment, 9, SART–S23546.
BruhnA.NylanderP. Å.JohnsenB. (2017). From prison guards to. . . what? Occupational development of prison officers in Sweden and Norway. Journal of Scandinavian Studies in Criminology and Crime Prevention, 18(1), 68–83
13.
CarpentierC.RoyuelaL.MontanariL.DavisD. (2018). The global epidemiology of drug use in prison. In KinnerS. A.RichJ. D. (Eds.), Drug use in prisoners. Epidemiology, implications and policy responses (pp. 19–41). Oxford University Press.
14.
CarpentierC.RoyuelaL.NoorA.HedrichD. (2012). Ten years of monitoring illicit drug use in prison populations in Europe: Issues and challenges. The Howard Journal of Criminal Justice, 51(1), 37–66.
15.
ChandlerR. K.FletcherB. W.VolkowN. D. (2009). Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. JAMA, 301(2), 183–190.
16.
ChesneyE.GoodwinG. M.FazelS. (2014). Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry, 13(2), 153–160.
17.
CopeN. (2000). Drug use in prison: The experience of young offenders. Drugs: Education, Prevention and Policy, 7(4), 355–366.
18.
CoyneC. J.HallA. (2017). Four decades and counting: The continued failure of the war on drugs. Cato Institute Policy Analysis, 811, 1–27.
19.
CreweB. (2005). Prisoner society in the era of hard drugs. Punishment & Society, 7(4), 457–481.
20.
DeBeckK.KerrT.LiK.MilloyM. J.MontanerJ.WoodE. (2009). Incarceration and drug use patterns among a cohort of injection drug users. Addiction, 104(1), 69–76.
21.
DegenhardtL.BucelloC.MathersB.BrieglebC.AliH.HickmanM.McLarenJ. (2011). Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction, 106(1), 32–51.
22.
DegenhardtL.LarneyS.KimberJ.GisevN.FarrellM.DobbinsT.WeatherburnD.J.GibsonA.MattickR.ButlerT.BurnsL. (2014). The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study. Addiction, 109(8), 1306–1317.
23.
DolanK. A.MoazenB.NooriA.RahimzadehS.FarzadfarF.HarigaF. (2015). People who inject drugs in prison: HIV prevalence, transmission and prevention. International Journal of Drug Policy, 26, S12–S15.
24.
DolanK. A.ShearerJ.MacDonaldM.MattickR. P.HallW.WodakA. D. (2003). A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug and Alcohol Dependence, 72(1), 59–65.
25.
DukeK. (2001). Evidence-based policy making? The interplay between research and the development of prison drugs policy. Criminal Justice, 1(3), 277–300.
26.
EngboH. J. (2017). Normalisation in Nordic prisons—From a prison governor’s perspective. In Scharff SmithP.UgelvikT. (Eds.), Scandinavian penal history, culture and prison practice (pp. 327–352). Palgrave Macmillan.
27.
Esping-AndersenG.KorpiW. (1987). From poor relief to institutional welfare states: The development of Scandinavian social policy. ME Sharpe.
28.
FairH.WalmsleyR. (2021). World prison population list. Institute for Crime & Justice Policy Research.
29.
FarrellM.SingletonN.StrangJ. (2000). Drugs and prison: A high risk and high burden environment. In ShewanD.DaviesJ. B. (Eds.) Drug use and prisons: An international perspective (pp. 203–213), CRC press.
30.
FazelS.BaillargeonJ. (2011). The health of prisoners. The Lancet, 377(9769), 956–965.
31.
FrenchM. T.McGearyK. A.ChitwoodD. D.McCoyC. B.InciardiJ. A.McBrideD. (2000). Chronic drug use and crime. Substance Abuse, 21(2), 95–109.
32.
FriestadC. (2010). Socio-economic status and health in a marginalized group: The role of subjective social status among prison inmates. European Journal of Public Health, 20(6), 653–658.
33.
GeorgeS.ClaytonS.NamboodiriV.BoulayS. (2009). “Up yours”: Amuggling illicit drugs into prison. Case Reports, 2009, bcr0620091935.
34.
GiertsenH. (2012). Policy on drugs in Norwegian prisons: Increased control, answers to poverties and looking for a life after release. Nordic Studies on alcohol and Drugs, 29(6), 589–604.
35.
GiordanoP. C.CernkovichS. A.RudolphJ. L. (2002). Gender, crime, and desistance: Toward a theory of cognitive transformation. American Journal of Sociology, 107(4), 990–1064.
36.
GlasserI. (1999). American drug laws: The new Jim Crow. Albany Law Review, 63, 703.
37.
GomesH. S.FarringtonD. P.MaiaA.KrohnM. D. (2019). Measurement bias in self-reports of offending: A systematic review of experiments. Journal of Experimental Criminology, 15(3), 313–339.
HauskenA. M.SkurtveitS.RosvoldE. O.BramnessJ. G.FuruK. (2007). Psychotropic drug use among persons with mental distress symptoms: A population-based study in Norway. Scandinavian Journal of Public Health, 35(4), 356–364.
40.
HavnesI. A.BuktenA.RognliE. B.MullerA. E. (2020). Use of anabolic-androgenic steroids and other substances prior to and during imprisonment-Results from the Norwegian Offender Mental Health and Addiction (NorMA) study. Drug and Alcohol Dependence, 217, 108255.
41.
HavivN.HasisiB. (2019). Prison addiction program and the role of integrative treatment and program completion on recidivism. International Journal of Offender Therapy and Comparative Criminology, 63(15–16), 2741–2770.
42.
HøidalA. (2018). Normality behind the walls: Examples from Halden Prison. Federal Sentencing Reporter, 31(1), 58–66.
43.
InciardiJ. A.LockwoodD.QuintanJ. A. (1993). Drug use in prison: Patterns, processes, and implications for treatment. Journal of Drug Issues, 23(1), 119–129.
44.
JohnsenB.GranheimP. K. (2011). Prison size and quality of life in Norwegian closed prisons in late modernity. In UgelvikT.DullumJ. (Eds.), Penal exceptionalism? (pp. 211–226). Routledge.
45.
JohnsenB.GranheimP. K.HelgesenJ. (2011). Exceptional prison conditions and the quality of prison life: Prison size and prison culture in Norwegian closed prisons. European Journal of Criminology, 8(6), 515–529.
46.
JongenelisM.PettigrewS.LawrenceD.RikkersW. (2019). Factors associated with poly drug use in adolescents. Prevention Science, 20(5), 695–704.
47.
KrauszM. R.JangK. L. (2018). North American opioid crisis: Decline and fall of the war on drugs. The Lancet Psychiatry, 5(1), 6–8.
48.
LangelidT. (1999). The sharing of responsibility in the rehabilitation of prisoners in Norway: The import-model in theory & practice. Journal of Correctional Education, 50(2), 52–61.
49.
Lappi-SeppäläT. (2007). Penal policy in Scandinavia. Crime and Justice, 36(1), 217–295.
50.
LarsenB. K.HeanS.ØdegårdA. (2019). A conceptual model on reintegration after prison in Norway. International Journal of Prisoner Health, 15(3), 282–292.
51.
LobmaierP. P.BermanA. H.GossopM.RavndalE. (2013). Substance use and problem awareness among drug-involved prisoners in Norway. Journal of Substance Use, 18(3), 211–220.
52.
LokdamN. TStavsethM.BuktenA. (2021). Exploring the external validity of survey data with triangulation: A case study from the Norwegian offender Mental Health and Addiction (NorMA) Study. Research Methods in Medicine & Health Science, 2(4), 140–147.
53.
McIntoshJ.SavilleE. (2006). The challenges associated with drug treatment in prison. Probation Journal, 53(3), 230–247.
54.
MjålandK. (2014). ‘A culture of sharing’: Drug exchange in a Norwegian prison. Punishment & Society, 16(3), 336–352.
55.
MjålandK. (2016). Exploring prison drug use in the context of prison-based drug rehabilitation. Drugs: Education, Prevention and Policy, 23(2), 154–162.
56.
MullerA. E.HavnesI. A.RognliE. B.BuktenA. (2018). Inmates with harmful substance use increase both exercise and nicotine use under incarceration. International Journal of Environmental Research and Public Health, 15(12), 2663.
57.
NurcoD. N.HanlonT. E.KinlockT. W. (1991). Recent research on the relationship between illicit drug use and crime. Behavioral Sciences & the Law, 9(3), 221–242.
58.
O’HaganA.HardwickR. (2017). Behind bars: The truth about drugs in prisons. Forensic Research & Criminology International Journal, 5(3), 00158.
PlourdeC.BrochuS. (2002). Drugs in prison: A break in the pathway. Substance Use & Misuse, 37(1), 47–63.
62.
PrattJ. (2008a). Scandinavian exceptionalism in an era of penal excess. Part I: The nature and roots of Scandinavian exceptionalism. The British Journal of Criminology, 48(2), 119–137.
63.
PrattJ. (2008b). Scandinavian exceptionalism in an era of penal excess: Part II: Does Scandinavian exceptionalism have a future?. The British Journal of Criminology, 48(3), 275–292.
64.
SingletonN.FarrellM.MeltzerH. (1999). Substance misuse among prisoners in England and Wales. Office for National Statistics.
65.
SkardhamarT.SkirbekkV. (2013). Relative mortality among criminals in Norway and the relation to drug and alcohol related offenses. PLoS One, 8(11), e78893.
66.
SmithP. S. (2011). A critical look at Scandinavian exceptionalism: Welfare state theories, penal populism and prison conditions in Denmark and Scandinavia. In UgelvikT.DullumJ. (Eds.), Penal Exceptionalism? (pp. 50–69). Routledge.
67.
SmithP. S. (2015). Children of imprisoned parents in Scandinavia: Their problems, treatment and the role of Scandinavian penal culture. Law in Context, 32, 147–168.
68.
SmithP. S.UgelvikT. (2017). Punishment and welfare in Scandinavia. In Scharff SmithP.UgelvikT. (Eds.), Scandinavian penal history, culture and prison practice (pp. 511–529). Palgrave Macmillan.
69.
StuartA.RichJ. D. J. (Eds.). (2018). Drug use in prisoners: Epidemiology, implications, and policy responses. Oxford University Press.
70.
TonryM. (1994). Race and the war on drugs. University of Chicago Legal Forum, 25, 25–81.
71.
PierceM.HayhurstK.BirdS. M.HickmanM.SeddonT.DunnG.MillarT. (2017). Insights into the link between drug use and criminality: Lifetime offending of criminally-active opiate users. Drug and Alcohol Dependence, 179, 309–316.
72.
RalphsR.WilliamsL.AskewR.NortonA. (2017). Adding spice to the porridge: The development of a synthetic cannabinoid market in an English prison. International Journal of Drug Policy, 40, 57–69.
73.
RocheleauA. M. (2015). Ways of coping and involvement in prison violence. International Journal of Offender Therapy and Comparative Criminology, 59(4), 359–383.
van den BergJ. J.AdeyemoS.RobertsM. B.BockB. C.SteinL. A. R.MartinR. A.ParkerD. R.ClarkeJ. G. (2018). Comparing the validity of self-report and urinalysis for substance use among former inmates in the Northeastern United States: Substance use reporting accuracy among inmates. Substance Use & Misuse, 53(10), 1756–1761.
76.
Van Der MeulenE. (2017). “It goes on everywhere”: Injection drug use in Canadian federal prisons. Substance Use & Misuse, 52(7), 884–891.
77.
VibekeF. A.KolindT. (2012). Prison-based drug treatment and rehabilitation in the Nordic countries. Nordic Studies on Alcohol and Drugs, 29(6), 542.
78.
VolkowN. D.PoznyakV.SaxenaS.GerraG.NetworkU. W. (2017). Drug use disorders: Impact of a public health rather than a criminal justice approach. World Psychiatry, 16(2), 213.
79.
WalmselyR. (2016). World prison brief. World prison population list. Institute for Criminal Policy Research; University of London.
80.
WerbD. (2018). Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs. International Journal of Drug Policy, 51, 160–164.
81.
WooldredgeJ. (2020). Prison culture, management, and in-prison violence. Annual Review of Criminology, 3, 165–188.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
